Document is current
Any future updates will be listed below
-
Authors
Rinella, Mary E. https://orcid.org/0000-0003-0620-9705
Sookoian, Silvia https://orcid.org/0000-0001-5929-5470
- License Information
-
More Information
Article History
Accepted: 24 February 2026
First Online: 18 March 2026
Competing interests
: M.E.R. has provided scientific consulting for Akero, Altimmune, 89Bio, Boehringer Ingelheim, Intercept Pharmaceuticals, Histoindex, Madrigal, NGM Biopharmaceuticals, Novo Nordisk, Eli Lilly, Sagimet Biosciences, Sonic Incytes, Cytodyn, GSK, Regeneron and Roche. S.S. declares no competing interests.
: The authors acknowledge that papers authored by scholars from historically excluded groups are systematically under-cited. Every attempt has been made to reference relevant papers in a manner that is equitable in terms of racial, ethnic, gender and geographical representation.
